Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Journal of Nanobiotechnology Année : 2020

Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules

Laura Pinton
  • Fonction : Auteur
Sara Magri
  • Fonction : Auteur
Elena Masetto
  • Fonction : Auteur
Marina Vettore
  • Fonction : Auteur
Ilaria Schibuola
  • Fonction : Auteur
Vincenzo Ingangi
  • Fonction : Auteur
Kevin Matha
Alessandro Della Puppa
  • Fonction : Auteur
Vincenzo Bronte
  • Fonction : Auteur
Susanna Mandruzzato
  • Fonction : Auteur
  • PersonId : 1065069

Résumé

Background: Myeloid derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) are two of the major players involved in the inhibition of anti-tumor immune response in cancer patients, leading to poor prognosis. Selective targeting of myeloid cells has therefore become an attractive therapeutic strategy to relieve immunosup-pression and, in this frame, we previously demonstrated that lipid nanocapsules (LNCs) loaded with lauroyl-modified gemcitabine efficiently target monocytic MDSCs in melanoma patients. In this study, we investigated the impact of the physico-chemical characteristics of LNCs, namely size and surface potential, towards immunosuppressive cell targeting. We exploited myeloid cells isolated from glioblastoma patients, which play a relevant role in the immunosup-pression, to demonstrate that tailored nanosystems can target not only tumor cells but also tumor-promoting cells, thus constituting an efficient system that could be used to inhibit their function. Results: The incorporation of different LNC formulations with a size of 100 nm, carrying overall positive, neutral or negative charge, was evaluated on leukocytes and tumor-infiltrating cells freshly isolated from glioblastoma patients. We observed that the maximum LNC uptake was obtained in monocytes with neutral 100 nm LNCs, while positively charged 100 nm LNCs were more effective on macrophages and tumor cells, maintaining at low level the incorporation by T cells. The mechanism of uptake was elucidated, demonstrating that LNCs are incorporated mainly by caveolae-mediated endocytosis. Conclusions: We demonstrated that LNCs can be directed towards immunosuppressive cells by simply modulating their size and charge thus providing a novel approach to exploit nanosystems for anticancer treatment in the frame of immunotherapy.
Fichier principal
Vignette du fichier
Pinto,_2020_Targeting of immunosuppressive myeloid cell from GBM patients by modulaiton of size and surface charge of LNC.pdf (2.81 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02482506 , version 1 (18-02-2020)

Licence

Paternité

Identifiants

Citer

Laura Pinton, Sara Magri, Elena Masetto, Marina Vettore, Ilaria Schibuola, et al.. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules. Journal of Nanobiotechnology, 2020, 18 (31), pp.1-12. ⟨10.1186/s12951-020-00589-3⟩. ⟨hal-02482506⟩
95 Consultations
153 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More